5-methylcytosine has been researched along with Cancer of Gastrointestinal Tract in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Asai, A; Doki, Y; Ishii, H; Kano, Y; Kawamoto, K; Konno, M; Koseki, J; Kudo, T; Matsui, H; Mori, M; Nishida, N; Sakai, D; Satoh, T | 1 |
1 other study(ies) available for 5-methylcytosine and Cancer of Gastrointestinal Tract
Article | Year |
---|---|
Computational trans-omics approach characterised methylomic and transcriptomic involvements and identified novel therapeutic targets for chemoresistance in gastrointestinal cancer stem cells.
Topics: 5-Methylcytosine; Animals; Antineoplastic Agents; Cell Line, Tumor; Cisplatin; DNA Methylation; Drug Resistance, Neoplasm; Female; Fluorouracil; Gastrointestinal Neoplasms; Humans; Mice; Mice, Inbred NOD; Mice, SCID; Neoplastic Stem Cells; Transcriptome | 2018 |